Primary small cell carcinoma of
oesophagus with syndrome of inappropriate antidiuretic hormone
secretion in a young child - a case report with review of literature
Ravindran M 1, Latha
S.M.2, Shriram A 3, Soundarapandian L.P 4 , Scott J.5, Srinivasan S 6,
Swaminathan R 7, Ramasundaram M 8
1Dr. Manipriya Ravindran, Postgraduate, 2Dr. Sneha M Latha, Pediatrics,
Assistant Professor, Division of Pediatric Hemato Oncology, 3Dr. Arun
Shriram Postgraduate Trainee, 4Dr. Soundarapandian Lakshmi Priya
Medical Officer, Division of Pediatric Oncology, 5Dr. Julius Scott,
Paediatrics, Fellowship in Paediatric Hemato Oncology(Australia), Head,
Division of Pediatric Hemato Oncology, 6Dr. Satish Srinivasan, RT,
Radiation Oncologist, Department of Medical Oncology, 7Dr. Rajendran
Swaminathan, Dip.R.C. Path, AB (AP & CP), AB(cytology),
Professor of Pathology, Department of Pathology, 8Dr. Madhu
Ramasundaram, S., Pediatric Surgeon, Department of Pediatric Surgery;
all authors are affiliated with Sri Ramachandra University.
Address for
Correspondence: Dr. Julius Scott, Professor of
Pediatrics, Division of Pediatric Hemato Oncology, Sri Ramachandra
Medical Centre, No.1, Ramachandra Nagar, Porur, Chennai. Email:
jxscott@hotmail.com
Abstract
Gastrointestinal malignancies are in general, infrequent among children
and oesophageal carcinomas in particular are extremely rare among the
paediatric age group. Small Cell Carcinoma of Oesophagus (SCC) is a
highly progressive tumour and is associated with a poor prognosis and
prone to early dissemination. Syndrome of inappropriate antidiuretic
hormone secretion (SIADH) occurs often (10%) as a paraneoplastic
syndrome in small cell carcinoma of lung, its occurrence in SCC of
oesophagus is very rare even in adults. We report a seven year old boy
who had small cell carcinoma of oesophagus who also had SIADH.
Key words: Small
Cell Carcinoma of Oesophagus, children, SIADH
Manuscript
received: 10th August 2016, Reviewed: 25th
August 2016
Author Corrected;
8th September 2016,
Accepted for Publication: 21st September 2016
Introduction
Small Cell Carcinoma of Oesophagus (SCC) is a highly progressive tumour
and is associated with a poor prognosis and prone to early
dissemination. Extensive review of literature revealed only very few
case reports on small cell carcinoma of the oesophagus in children
probably because these malignancies have a long latent period of
carcinogenesis. Syndrome of inappropriate antidiuretic hormone
secretion (SIADH) occurs often (10%) as a paraneoplastic syndrome in
small cell carcinoma of lung, its occurrence in SCC of oesophagus is
very rare even in adults [1].
Case
Report
A 7 years old male child presented with complaints of cough, breathing
difficulty and severe fatigue of 20 days duration. There was no history
of pain during deglutition, weight loss, nausea, vomiting, diarrhoea or
constipation and chest pain. His parents also denied history of fever,
chills, jaundice, hematemesis, melena or hematochezia. There was no
history of accidental consumption of any corrosive substance. He did
not have any family history of oesophageal disorders, gastrointestinal
malignancies and other familial or genetic disorders. Antenatal, natal
and post natal history were non-contributory and he was immunized
appropriately for age.
Physical examination revealed a palpable right supraclavicular lymph
node of size 2x3cm. Laboratory investigations revealed low serum sodium
(112 mEq/L), elevated urinary sodium concentration (81 mEq/L), elevated
urine osmolality (380 mOsm/L) and elevated serum ADH levels (13
pg/mL).Chest X-ray showed widening of the mediastinum. (Figure 1a).
Axial and sagittal contrast enhanced computed tomographic sections at
the level of upper mediastinum showed circumferential wall thickening
of the oesophagus extending from C6 to T5 level, with multiple enlarged
lymph nodes in the mediastinum - paratracheal and subcarinal region
(Figure 1b).
Figure 1a.:
Chest x-ray [PA view] shows widening of the superior mediastinum,
silhouetting the margins of the arch of aorta - Suggestive of an
anterior, middle mediastinal mass probably enlarged lymph nodes
Figure 1b.: axial
and sagittal contrast computed tomographic sections at the level of
upper mediastinum shows long segment [8 cm] circumferential wall
thickening of the proximal esophagus with multiple lymph nodes in the
mediastinum (paratracheal and subcarinal region).
Upper GI scopy showed ulceroproliferative growth involving 2/3rd lumen
of thoracic oesophagus. Oesophageal biopsy showed acute esophagitis.
Right supraclavicular lymph node biopsy revealed multiple islands of
small cell tumor separated by wide bands of loose fibrous tissue (
figure 2a). The small spindle cells showed scanty cytoplasm, large
nuclei with stippled chromatin and increased mitosis. Some foci showed
thin fibrillary cytoplasm around these cells. Immunohistochemistry
showed strong positivity for vimentin, EMA, chromogranin,
synaptophysin, while P63, CD 99, Myogenin, Desmin, S100, CD45, CD3,
CD20, CD10 were negative which confirmed the diagnosis to be Small Cell
Carcinoma (SCC), poorly differentiated neuroendocrine carcinoma (Fig
2b).
Fig-2a: Lymphnode
with partially effaced architecture with Nests of tumor cells seen
surrounded by sclerotic stroma, cells are showing severe pleomorphism
and increased mitosis 12/10 hpf and several apoptosis
Fig-2b: by
IHC tumor cells were positive for synaptophysin , chromogranin, S100
and EMA. Histology and IHC are in the favor of small cell carcinoma (
poorly differentiated neuro endocrine tumor)
USG Abdomen, CT abdomen and 24 hr urinary VMA was normal. Bone marrow
biopsy, bone scan and MIBG were all also found to be insignificant.
With diagnosis of SCC of oesophagus the child received 4 cycles of
cisplatin and etoposide, followed by radiotherapy with 50 Gy in 28
fractions. Post radiotherapy he was followed up with 2 more cycles of
cisplatin and etoposide. PET scan done 6 weeks after the last
chemotherapy was normal.
During follow up-
3 months after completion of treatment, child presented with same
symptoms and found to have relapse. The family opted for alternative
medicine and the child reportedly succumbed to the disease, three
months from the relapse.
Discussion
Gastrointestinal malignancies are in general, infrequent among children
and esophageal carcinomas in particular are extremely rare among the
pediatric age group. Small cell carcinoma (SCC) occurs more commonly in
the lung. The incidence of SCC in esophagus is rarely reported
accounting for only 0.8-2.4% of all esophageal cancers in adults [2].
Primary SCC of the esophagus was first reported in 1952 by Mckeown in
an adult patient [3,4]. SCC usually occurs in the sixth or seventh
decade of life but ranges from 29-88 years (mean 64years). SCC of the
esophagus is a highly progressive tumour and is associated with a poor
prognosis. These tend not to occur in children probably because these
malignancies have a long latent period of carcinogenesis.
The etiologies of esophageal cancer are usually attributed to the habit
of cigarette smoking and high alcoholic beverage consumption. The
premalignant condition reported is Barett’s esophagus.
Factors associated with low risk of esophageal cancer are high intake
of fruit and vegetables. Folate, fibre, β-carotene, vitamin C,
vitamin D and B6 were inversely associated with risk of SCC of
oesophagus whereas dietary cholesterol, vitamin B12 and animal protein
were positively associated with SCC of oesophagus [5]. Salivary glands,
pharynx, larynx, esophagus, stomach, pancreas, colon, rectum, skin and
cervix are the most common extrapulmonary sites of SCC [6].
There are two histological origin of SCC. They either originate from
the neuroendocrine cells of the submucosal gland or stratum basal or
from the multi potential stem cells of the endoderm.
Immunohistochemical staining of the biopsied cells is vital to
determine the carcinoma. In this case, there was positive staining for
the neuroendocrine markers, synaptophysin and chromogranin A. SCC has
been found to be of mixed type 63%of the time, demonstrating coexisting
adenocarcinomatous and squamous cell histological characteristics.
Many patients are asymptomatic while some other present with dysphagia
and weight loss as a common presenting symptom. Other symptoms include
dyspepsia, chest pain, hematemesis and rarely syndrome of inappropriate
antidiuretic hormone (SIADH) [7].
SIADH is thought to be due to ADH producing tumor cells which is seen
predominantly after recurrence [8].
SCC of the esophagus is being treated with various treatment modalities
which include surgical resection, chemotherapy, radiotherapy and
combinations of therapy. While there is currently no formal treatment
of esophageal SCC due to the paucity of cases, chemotherapy appears to
be the most effective treatment.
Historically in adults the 5 year survival rates were <10% with
surgery or radiotherapy alone due to early dissemination of the disease
and up to 25 % when chemotherapy and radiotherapy were combined [9].
Later other combination used were cisplatin, etoposide, alternating
with cyclophosphamide, doxorubicin and vincristine[10]. Other
chemotherapy agents tried with success paclitaxel, irinotecan,
oxaliplatin, and vinorelbine [11].
Conclusion
Small cell carcinoma of esophagus is a clinically challenging and very
rare tumor in children with a poor prognosis. Accurate diagnosis with
immunohistochemistry coupled with multimodality treatment is the basis
of management of this tumour. Multicentre studies for this kind of
tumors and shared protocols will help in future to develop standard
treatment guidelines for this tumor.
Funding:
Nil, Conflict of
interest: Nil
Permission from IRB:
Yes
References
1. Hansen O, Sørensen P,
Hansen KH. The occurrence of hyponatremia in SCLC and the influence on
prognosis: a retrospective study of 453 patients treated in a single
institution in a 10-year period. Lung Cancer. 2010 Apr; 68(1):111-4. [PubMed]
2. Beyer KL, Marshall JB, Diaz-Arias AA, Loy TS. Primary small-cell
carcinoma of the esophagus. Report of 11 cases and review of the
literature. J Clin Gastroenterol. 1991 Apr;13(2):135-41. [PubMed]
3. MCKEOWN F. Oat-cell carcinoma of the oesophagus. J Pathol Bacteriol.
1952 Oct;64(4):889-91. [PubMed]
4. Lichtenstein S, Albert NE, Muchnik A, Abraham
M. Small cell carcinoma: an unusual location in a young healthy female.
J Gastrointestin Liver Dis. 2011 Dec;20(4):427-30. [PubMed]
5. Mayne ST, Risch HA, Dubrow R, Chow WH, Gammon
MD, Vaughan TL, Farrow DC, Schoenberg JB, Stanford JL, Ahsan H, West
AB, Rotterdam H, Blot WJ, Fraumeni JF Jr. Nutrient intake and risk of
subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers
Prev. 2001 Oct;10(10):1055-62.
6. Shamelian SO, Nortier JW. Extrapulmonary
small-cell carcinoma: report of three cases and update of therapy and
prognosis. Neth J Med. 2000 Feb;56(2):51-5. [PubMed]
7. Beyer KL, Marshall JB, Diaz-Arias AA, Loy TS.
Primary small-cell carcinoma of the esophagus. Report of 11 cases and
review of the literature. J Clin Gastroenterol. 1991 Apr;13(2):135-41. [PubMed]
8. Ando T, Hosokawa A, Yamawaki H, Hasumoto Y,
Kajiura S, Itaya Y, Ueda A, Suzuki N, Nishikawa J, Fujinami H, Miyazaki
T, Ogawa K, Sugiyama T. Esophageal small-cell carcinoma with syndrome
of inappropriate secretion of antidiuretic hormone. Intern Med.
2011;50(10):1099-103. [PubMed]
9. Al-Sarraf M, Martz K, HerskovicA et
al. Progress report of combined chemoradiotherapy versus radiotherapy
alone in patients with esophageal cancer: an Intergroup Study. J Clin
Oncol 1999; 15: 277–284.
10 .Kelsen DP, Weston E, Kurtz R et al
Small-cell carcinoma of the esophagus Treatment by chemotherapy alone
Cancer 1980, 45 1558-61. [PubMed]
11. Enzinger PC, Ilson DH, Kelsen DP.
Chemotherapy in esophageal cancer. Semin Oncol. 1999 ; 26 :12-20. [PubMed]
How to cite this article?
Ravindran M, Latha S.M, Shriram A, Soundarapandian L.P,
Scott J, Srinivasan S, Swaminathan R, Ramasundaram M. Primary small
cell carcinoma of oesophagus with syndrome of inappropriate
antidiuretic hormone secretion in a young child - a case report with
review of literature.Int. J Pediatr Res.
2016;3(9):692-696.doi:10.17511/ijpr.2016.9.12.